ALTIMMUNE, INC. Public Float
ALTIMMUNE, INC. (ALT) had Public Float of $326.80 million as of 2025-06-30, per its 10-K filed 2026-03-06.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-03-06
- 2025-06-30: Entity Public Float $326.80M.
- 2024-06-30: Entity Public Float $469.00M.
- 2023-06-30: Entity Public Float $184.40M.
- 2022-06-30: Entity Public Float $537.90M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $326.80M 10-K · filed 2026-03-06 |
| 2024-06-30 | $469.00M 10-K · filed 2025-02-27 |
| 2023-06-30 | $184.40M 10-K · filed 2024-03-27 |
| 2022-06-30 | $537.90M 10-K · filed 2023-02-28 |
| 2021-06-30 | $386.70M 10-K · filed 2022-03-15 |
| 2020-06-30 | $280.60M 10-K · filed 2021-02-25 |
| 2019-06-28 | $28.79M 10-K · filed 2020-03-27 |
| 2018-06-30 | $12.30M 10-K · filed 2019-04-01 |
| 2017-06-30 | $49.40M 10-K · filed 2018-04-02 |
| 2016-06-30 | $133.90M 10-K · filed 2017-03-14 |
| 2015-06-30 | $81.00M 10-K · filed 2016-03-11 |
| 2014-06-30 | $56.00M 10-K · filed 2015-03-11 |
| 2013-06-28 | $69.00M 10-K · filed 2014-03-11 |
| 2012-06-29 | $56.30M 10-K · filed 2013-03-14 |
| 2011-06-30 | $104.00M 10-K · filed 2012-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B |